Primary |
Product Used For Unknown Indication |
31.3% |
Drug Use For Unknown Indication |
16.5% |
Pain |
10.0% |
Osteoarthritis |
5.2% |
Back Pain |
4.5% |
Suicide Attempt |
4.5% |
Pyrexia |
4.4% |
Hypertension |
4.1% |
Headache |
3.3% |
Rheumatoid Arthritis |
2.9% |
Arthralgia |
2.4% |
Arthritis |
1.8% |
Depression |
1.5% |
Toothache |
1.4% |
Migraine |
1.1% |
Prophylaxis |
1.1% |
Foetal Exposure During Pregnancy |
1.1% |
Intentional Overdose |
1.0% |
Thrombosis Prophylaxis |
1.0% |
Ill-defined Disorder |
1.0% |
|
Renal Failure Acute |
12.4% |
Vomiting |
12.0% |
Completed Suicide |
7.4% |
Drug Hypersensitivity |
6.6% |
Gastrointestinal Haemorrhage |
5.4% |
Overdose |
5.4% |
Death |
5.2% |
Toxicity To Various Agents |
4.9% |
Renal Failure |
4.2% |
Drug Toxicity |
4.1% |
Toxic Epidermal Necrolysis |
3.7% |
Urticaria |
3.6% |
Tachycardia |
3.5% |
Drug Ineffective |
3.4% |
Suicide Attempt |
3.3% |
Stevens-johnson Syndrome |
3.2% |
Intentional Overdose |
3.2% |
Weight Decreased |
3.1% |
Haematemesis |
2.8% |
Tubulointerstitial Nephritis |
2.6% |
|
Secondary |
Product Used For Unknown Indication |
26.7% |
Drug Use For Unknown Indication |
14.4% |
Osteoarthritis |
10.1% |
Rheumatoid Arthritis |
8.5% |
Pain |
7.2% |
Hypertension |
4.0% |
Headache |
3.5% |
Pyrexia |
3.3% |
Suicide Attempt |
2.5% |
Arthritis |
2.4% |
Back Pain |
2.4% |
Arthralgia |
2.2% |
Foetal Exposure During Pregnancy |
2.2% |
Depression |
2.0% |
Prophylaxis |
2.0% |
Drug Abuse |
1.6% |
Intentional Overdose |
1.4% |
Fibromyalgia |
1.3% |
Pain In Extremity |
1.2% |
Migraine |
1.2% |
|
Vomiting |
13.1% |
Completed Suicide |
12.2% |
Renal Failure Acute |
10.4% |
Suicide Attempt |
8.2% |
Toxicity To Various Agents |
5.8% |
Drug Ineffective |
5.0% |
Weight Decreased |
4.9% |
Respiratory Arrest |
4.1% |
Tachycardia |
3.6% |
Drug Hypersensitivity |
3.4% |
Intentional Overdose |
3.2% |
Dyspepsia |
3.1% |
Gastrointestinal Haemorrhage |
3.0% |
Toxic Epidermal Necrolysis |
3.0% |
Death |
2.9% |
Drug Toxicity |
2.9% |
Somnolence |
2.9% |
Overdose |
2.8% |
Renal Failure |
2.8% |
Urticaria |
2.5% |
|
Concomitant |
Product Used For Unknown Indication |
26.5% |
Drug Use For Unknown Indication |
13.1% |
Pain |
11.6% |
Rheumatoid Arthritis |
6.9% |
Hypertension |
4.7% |
Contraception |
4.5% |
Depression |
4.4% |
Multiple Sclerosis |
3.7% |
Headache |
2.6% |
Anxiety |
2.4% |
Prophylaxis |
2.3% |
Asthma |
2.3% |
Back Pain |
2.2% |
Acne |
2.1% |
Hepatitis C |
2.1% |
Gastrooesophageal Reflux Disease |
2.0% |
Premenstrual Syndrome |
1.9% |
Premedication |
1.6% |
Migraine |
1.6% |
Hiv Infection |
1.6% |
|
Vomiting |
13.0% |
Pain |
10.7% |
Pulmonary Embolism |
10.1% |
Weight Decreased |
6.9% |
Weight Increased |
6.0% |
Drug Ineffective |
5.2% |
Deep Vein Thrombosis |
5.1% |
Nausea |
4.6% |
Headache |
3.7% |
Pain In Extremity |
3.7% |
Vision Blurred |
3.6% |
Urinary Tract Infection |
3.5% |
Pyrexia |
3.4% |
Rash |
3.0% |
Injury |
2.9% |
Tremor |
2.9% |
Flushing |
2.9% |
Thrombosis |
2.9% |
Pruritus |
2.8% |
Dyspnoea |
2.8% |
|
Interacting |
Product Used For Unknown Indication |
28.9% |
Pain |
11.8% |
Hypertension |
9.4% |
Back Pain |
8.0% |
Drug Use For Unknown Indication |
4.5% |
Atrial Fibrillation |
4.0% |
Influenza Like Illness |
3.6% |
Rheumatoid Arthritis |
3.6% |
Gastroenteritis |
3.3% |
Lymphadenopathy |
3.3% |
Cardiac Failure |
2.9% |
Arthritis |
2.7% |
Pseudomonas Infection |
2.4% |
Systemic Lupus Erythematosus |
2.0% |
Arthralgia |
1.6% |
Bladder Pain |
1.6% |
Depression |
1.6% |
Dysmenorrhoea |
1.6% |
Osteitis |
1.6% |
Thrombosis Prophylaxis |
1.6% |
|
Drug Interaction |
22.8% |
Renal Failure Acute |
11.4% |
Weight Decreased |
8.8% |
International Normalised Ratio Increased |
6.1% |
Upper Gastrointestinal Haemorrhage |
5.3% |
Toxicity To Various Agents |
4.4% |
Vomiting |
4.4% |
Gastric Ulcer Haemorrhage |
3.5% |
Gastrointestinal Haemorrhage |
3.5% |
Headache |
3.5% |
Pain |
3.5% |
Pneumonia |
3.5% |
Dermatitis Exfoliative |
2.6% |
Haematemesis |
2.6% |
Hypotension |
2.6% |
Neutropenia |
2.6% |
Supraventricular Tachycardia |
2.6% |
White Blood Cell Count Increased |
2.6% |
Back Pain |
1.8% |
Dyspnoea |
1.8% |
|